Fundraising Fox
/People
Sign in

Ken Song

InvestorFounder

Partner at Venrock · Chairman, President and CEO at Candid Therapeutics · Founder at Rayze Bio

San Diego, California, United States

FoundedCandid TherapeuticsRayze Bio

Find your path to Ken

117 people in our graph can introduce you to Ken.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Richard Heyman to introduce you to Ken

You →Richard · together at Rayze Bio →Ken

Ask Jamie Chen to introduce you to Ken

You →Jamie · 4 people · together at Rayze Bio →Ken

Ask Sam Okafor to introduce you to Ken

You →Sam · 2 people · together at Candid Therapeutics →Ken

Sign up to find every way you can get introduced to Ken

  • Your email: the people you already email who know Ken
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Ken
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Chairman, President and CEO at Candid Therapeutics

Intro paths

→

In turn, Ken can intro founders to Candid Therapeutics's investors below.

Candid Therapeutics's investors · 8

Foresite CapitalWest Hollywood · since 2024LifeSci Venture PartnersNew York · since 2024OrbiMedNew York · $1M – $75M checks · since 2024Samsara BioCapitalMenlo Park · since 2024TCG CrossoverPalo Alto · since 2024Third Rock VenturesBoston · $100K – $5M checks · since 2024venBio PartnersSan Francisco · since 2024Vida VenturesLos Angeles · since 2024

Co-founders at Candid Therapeutics

KSKenneth Song, M.D.
Kenneth Song, M.D.Executive Officer, Director

Founder at Rayze Bio

Intro paths

→

In turn, Ken can intro founders to Rayze Bio's investors below.

Rayze Bio's investors · 11

LifeSci Venture PartnersNew YorkSamsara BioCapitalMenlo Park · since 2020Scion Life SciencesNew York · $1K – $60M checksSofinnova VenturesMenlo Park · $100K – $15M checks · since 2022TCG CrossoverPalo AltovenBio Global StrategicSan Francisco · since 2022venBio PartnersSan Francisco · since 2020Versant VenturesSan Francisco · $250K – $5M checks · since 2020Viking GlobalStamfordVivo CapitalPalo Alto · $10M – $50M checksWellington ManagementBoston · $5M – $50M checks

Experience

  1. VenrockPartnercurrent2026 — present
  2. Averto Medical, IncExecutive Chairmancurrent2024 — presentFremont, California, United States
  3. ElevAAte BiotechCo-founder and Board membercurrent2024 — present
  4. Candid TherapeuticsPresident and CEO, Chairman of the Board2024 — 2026San Diego, CA
  5. Ablaze PharmaceuticalsChairman of the Board and Co-founder2021 — 2025Shanghai, China

Skills & more

Clinical DevelopmentBusiness Strategy

From Ken's professional profile.

Colleagues at Venrock

Abe Valdez
IT Manager at Venrock
Alex Rosen
Partner at Venrock
Andrew Gottesdiener
VHCP at Venrock
Andy Wardle
VHCP at Venrock
Bailie Salk
Investor at Venrock
Bambie Guzman
Office Manager & Executive Assistant at Venrock
Bob Kocher
Co-Founder of Lyra Health; Partner at Venrock
Bong Koh
Partner at KohFounders

Frequently asked questions

Who is Ken Song?
Partner at Venrock
Where does Ken Song work?
Ken Song is Chairman, President and CEO of Candid Therapeutics and Partner at Venrock and Co-founder at Rayze Bio.
What companies did Ken Song found?
Ken Song founded Candid Therapeutics, Rayze Bio.
Where did Ken Song go to school?
Ken Song studied at University of California, San Francisco - School of Medicine (MD, Medicine); Massachusetts Institute of Technology (BS, Biology).

Founder mafias

Same school

Shared employers

Also worked at Ablaze Pharmaceuticals1

Aaron RoystonManaging Partner at venBio Partners